-
14:43
-14:51
PRO Perspectives
-
14:51
-14:59
CON Perspectives
-
14:59
-15:19
Panel Discussion
-
15:19
-15:25
Voting and Summary
Debate 1: In the Post–KEYNOTE-B96 Era, Should Biomarker Selection Drive Clinical Trial Design?
2026-12-05 14:40-15:25
Hall B
Moderator:
Hidemichi Watari
14:43
-14:51
PRO Perspectives
14:51
-14:59
CON Perspectives
14:59
-15:19
Panel Discussion
15:19
-15:25
Voting and Summary